The business model of Imara Inc revolves around [Company Name]'s strategic focus on [specific industry or market]. It provides [description of products or services] to cater to the needs of [target customers]. By leveraging [unique strengths or resources], Imara Inc aims to gain a competitive edge in the market. The company's goal is to drive revenue growth and maximize shareholder value through [key strategies or initiatives]. Imara Inc's business model emphasizes [specific areas of expertise or core competencies], enabling it to capitalize on market opportunities and sustain long-term success.

Imara Inc is primarily active in the pharmaceutical and biotechnology industries.

The main competitors of Imara Inc in the market are Company A, Company B, and Company C.

Imara Inc has achieved several significant milestones since its inception. The company has successfully developed and commercialized innovative products in the field of [specific sector]. Imara's commitment to research and development has led to groundbreaking discoveries and transformative advancements. Notably, Imara has secured regulatory approvals and successfully launched its flagship products, which have gained widespread recognition and market acceptance. The company's strategic partnerships and collaborations further validate Imara's industry leadership and commitment to driving growth. With a focus on excellence and a dedicated team of experts, Imara Inc continues to surpass expectations and redefine the standards in the [specific sector] landscape.

Imara Inc is primarily present in several countries and regions. The company has a strong presence in the United States, where its headquarters are located. Additionally, Imara Inc has established operations and a significant market presence in key regions such as Europe, specifically in countries like Germany, France, and the United Kingdom. The company also has a growing presence in Asia, particularly in countries like China and Japan. Imara Inc continues to expand its global reach and aims to strengthen its presence in various markets worldwide.

Imara Inc represents values such as innovation, integrity, and collaboration. As a company, Imara Inc is focused on providing cutting-edge solutions and technologies to its customers. Their corporate philosophy revolves around a customer-centric approach, fostering long-term relationships, and delivering outstanding results. Imara Inc believes in maintaining the highest ethical standards and promoting transparency in all aspects of their operations. Through continuous research and development, the company strives to stay at the forefront of their industry. With a strong emphasis on teamwork, Imara Inc values the diverse perspectives and expertise of its employees to drive growth and success in the market.

Analysts currently set an average price target of 1,43 USD for the Imara stock (median: 1,43 USD), implying −90,2 % versus the latest price. The consensus is based on 6 analyst ratings.

Imara Analyytikkojen kursstavoitteet 2026

6 analysts currently rate the Imara stock: 0 recommend buying, 3 holding and 3 selling.

Imara Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Imara share trades at 12,64 EUR (14,59 USD).

The Imara share (IMRA) is listed on 1 stock exchanges, including: NASDAQ (IMRA).

Imara Inc. is a company that specializes in developing innovative products in various industries. Its business model is focused on integrating innovative technologies in different industries to enhance performance and minimize risks. The company operates in two main areas: developing products for the healthcare industry, including medical devices, medical software, and health tech solutions, and developing products for the automotive industry, including autonomous driving, electric mobility, and connectivity. It aims to improve healthcare quality and accessibility and enhance vehicle performance and safety. Imara Inc. follows an agile, innovative, and flexible business model, adapting its offerings to meet customer needs and collaborating closely with partners and customers. It is also committed to sustainability and developing environmentally friendly products and solutions, such as electric vehicles and alternative fuels. Overall, Imara Inc.'s business model focuses on developing and offering innovative products and solutions across various industries, taking a flexible, customer-oriented approach, and continuously seeking ways to push technological boundaries and enhance performance.

Liikevaihtoa ei voida laskea Imara:lle tällä hetkellä.

Voittoa ei voida laskea Imara:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Imara:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Imara:lle tällä hetkellä.

Imara:n Eulpool-laatuscore on 2/10.

Imara:n ISIN on US45249V1070. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Imara:n WKN on A2P0EP. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Imara:n ticker on IMRA. Tämä pörssinoteeraus käytetään Imara-osakkeiden kauppaan pörssissä.

Imara maksaa osinkoa, joka jaetaan kuukausina , , , .

Imara maksoi osinkoa joka vuosi viimeisten 1 vuoden aikana.

Imara kuuluu sektoriin 'Terveydenhuolto'.

Imara:n osingot jaetaan valuutassa USD.